ENTRY       D03217                      Drug
NAME        Avanafil (USAN/INN);
            Stendra (TN);
            Spedra (TN)
PRODUCT     STENDRA (Metuchen Pharmaceuticals)
FORMULA     C23H26ClN7O3
EXACT_MASS  483.1786
MOL_WEIGHT  483.9506
CLASS       Cardiovascular agent
             DG01509  Phosphodiesterase V inhibitor
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: G04BE10
            Product: D03217<US>
EFFICACY    Impotence therapy, Phosphodiesterase V inhibitor
COMMENT     Treatment of erectile dysfunction
TARGET      PDE5 [HSA:8654] [KO:K13762]
  PATHWAY   hsa04022(8654)  cGMP-PKG signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04B UROLOGICALS
                G04BE Drugs used in erectile dysfunction
                 G04BE10 Avanafil
                  D03217  Avanafil (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Sexual Disorder Agents
              Sexual Disorder Agents (Male)
               Avanafil
                D03217  Avanafil (USAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01509  Phosphodiesterase V inhibitor
               D03217  Avanafil
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D03217  Avanafil
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphodiesterases
                PDE5
                 D03217  Avanafil (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03217
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03217
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03217
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03217
DBLINKS     CAS: 330784-47-9
            PubChem: 17397370
            ChEBI: 66876
            PDB-CCD: E6L
            LigandBox: D03217
ATOM        34
            1   C8x C    20.4616  -14.1646
            2   C8x C    20.4616  -15.5680
            3   N5x N    21.6769  -16.2697
            4   C8y C    22.8924  -15.5680
            5   N5x N    22.8924  -14.1646
            6   C8x C    21.6769  -13.4629
            7   C1b C    24.1266  -16.2807
            8   N1b N    25.3347  -15.5833
            9   C5a C    26.5199  -16.2678
            10  C8y C    27.7168  -15.5768
            11  O5a O    26.5199  -17.6730
            12  C8y C    28.9075  -16.2644
            13  N5x N    30.1230  -15.5628
            14  C8y C    30.1231  -14.1594
            15  N5x N    28.9323  -13.4718
            16  C8x C    27.7169  -14.1734
            17  N1y N    31.3527  -13.4494
            18  N1b N    28.9075  -18.4430
            19  C1b C    30.1075  -19.1353
            20  C8y C    31.3249  -18.4320
            21  C1x C    31.3527  -12.0494
            22  C1y C    32.6842  -13.8820
            23  C1x C    33.5071  -12.7494
            24  C1x C    32.6842  -11.6168
            25  C8x C    32.5018  -19.1111
            26  C8y C    33.7140  -18.4108
            27  C8y C    33.7137  -17.0108
            28  C8x C    32.5368  -16.3317
            29  C8x C    31.3245  -17.0320
            30  O2a O    34.9459  -16.2987
            31  C1a C    36.1514  -16.9942
            32  X   Cl   34.9456  -19.1217
            33  C1b C    33.1110  -15.1952
            34  O1a O    34.5110  -15.1952
BOND        37
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    9  11 2
            12   10  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   10  16 1
            18   14  17 1
            19   12  18 1
            20   18  19 1
            21   19  20 1
            22   17  21 1
            23   17  22 1
            24   22  23 1
            25   23  24 1
            26   21  24 1
            27   20  25 2
            28   25  26 1
            29   26  27 2
            30   27  28 1
            31   28  29 2
            32   20  29 1
            33   27  30 1
            34   30  31 1
            35   26  32 1
            36   22  33 1 #Up
            37   33  34 1
///
